Dae-Geun Jeon
Research Subjects
Dae-Geun Jeon has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chang-Bae Kong
Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea
3 shared publicationsSeung Yong Lee
Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea
3 shared publicationsWan Hyeong Cho
Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea
3 shared publicationsWon Seok Song
Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea
3 shared publicationsBum Suk Kim
Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea
2 shared publications- Byung Hyun Byun
Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), 75 Nowongil, Nowon Gu, Seoul, 139-706, Republic of Korea,
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 52 (1) , 33-39
The Optimal Surgical Approach and Complications in Resecting Osteochondroma around the Lesser Trochanter
Jeon DG, et al. J Korean Orthop Assoc. 2017 Feb;52(1):33-39. https://doi.org/10.4055/jkoa.2017.52.1.33
- 1 January 2017
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 52 (1) , 33-39
Open AccessThe Optimal Surgical Approach and Complications in Resecting Osteochondroma around the Lesser Trochanter
Jeon DG, et al. J Korean Orthop Assoc. 2017 Feb;52(1):33-39. https://doi.org/10.4055/jkoa.2017.52.1.33
- Open Access
- 1 January 2016
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 51 (4) , 294-300
Surgical and Oncological Outcome of Pelvis Bone Tumor Patients with Type III Internal Hemipelvectomy
Jeon DG, et al. J Korean Orthop Assoc. 2016 Aug;51(4):294-300. http://dx.doi.org/10.4055/jkoa.2016.51.4.294
- 1 January 2016
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 51 (4) , 294-300
Open AccessSurgical and Oncological Outcome of Pelvis Bone Tumor Patients with Type III Internal Hemipelvectomy
Jeon DG, et al. J Korean Orthop Assoc. 2016 Aug;51(4):294-300. http://dx.doi.org/10.4055/jkoa.2016.51.4.294
- Open Access
- 1 January 2015
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 50 (3) , 225-231
Giant Cell-Rich Osteosarcoma: A Tumor Simulating Borderline Lesion
- 1 January 2015
- Published by The Korean Orthopaedic Association in Journal of the Korean Orthopaedic Association
- Vol. 50 (3) , 225-231
Open AccessGiant Cell-Rich Osteosarcoma: A Tumor Simulating Borderline Lesion
- 31 August 2013
- Published by Springer Nature in Skeletal Radiology
- Vol. 42 (12) , 1673-1681
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma
We compared the diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and (99 m)Tc-methylene diphosphonate bone scintigraphy (BS) for the detection of bone metastasis in osteosarcoma. We retrospectively reviewed 206 patients with stage II–IV osteosarcoma treated with surgery and chemotherapy as well as at least one paired PET/CT and BS scan (defined as an examination). PET/CT and BS images were interpreted separately. When analyzing the diagnostic yield of a combination of PET/CT and BS (PET/CT+BS), an examination was considered positive if either PET/CT or BS scored positive. The final diagnosis was obtained from histological findings or clinical follow-up with imaging studies for at least 6 months. Diagnostic performances of PET/CT, BS, and their combinations were calculated. Out of 833 examinations in 206 patients, 55 with 101 lesions in 38 patients were confirmed as bone metastases. The sensitivity, specificity, and diagnostic accuracy were 95, 98, and 98 %, respectively, for PET/CT; 76, 97, and 96 %, respectively, for BS; and 100, 96, and 97 %, respectively, for PET/CT+BS in an examination-based analysis. Lesion-based analysis demonstrated that the sensitivity of PET/CT+BS (100 %) was significantly higher than that of PET/CT (92 %) or BS (74 %) alone. BS detected significantly less bone metastases in the growth plate region than outside the growth plate region (22 vs. 77 %). PET/CT is more sensitive and accurate than BS for diagnosing bone metastases in osteosarcoma. The combined use of PET/CT and BS improves sensitivity.
- 31 August 2013
- Published by Springer Nature in Skeletal Radiology
- Vol. 42 (12) , 1673-1681
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma
We compared the diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and (99 m)Tc-methylene diphosphonate bone scintigraphy (BS) for the detection of bone metastasis in osteosarcoma. We retrospectively reviewed 206 patients with stage II–IV osteosarcoma treated with surgery and chemotherapy as well as at least one paired PET/CT and BS scan (defined as an examination). PET/CT and BS images were interpreted separately. When analyzing the diagnostic yield of a combination of PET/CT and BS (PET/CT+BS), an examination was considered positive if either PET/CT or BS scored positive. The final diagnosis was obtained from histological findings or clinical follow-up with imaging studies for at least 6 months. Diagnostic performances of PET/CT, BS, and their combinations were calculated. Out of 833 examinations in 206 patients, 55 with 101 lesions in 38 patients were confirmed as bone metastases. The sensitivity, specificity, and diagnostic accuracy were 95, 98, and 98 %, respectively, for PET/CT; 76, 97, and 96 %, respectively, for BS; and 100, 96, and 97 %, respectively, for PET/CT+BS in an examination-based analysis. Lesion-based analysis demonstrated that the sensitivity of PET/CT+BS (100 %) was significantly higher than that of PET/CT (92 %) or BS (74 %) alone. BS detected significantly less bone metastases in the growth plate region than outside the growth plate region (22 vs. 77 %). PET/CT is more sensitive and accurate than BS for diagnosing bone metastases in osteosarcoma. The combined use of PET/CT and BS improves sensitivity.